Nikko Asset Management Americas, Inc. Organovo Holdings, Inc. Transaction History

Nikko Asset Management Americas, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.41 - $2.17 $9,339 - $14,374	-6,624 Reduced 1.44%	454,752 $645,000
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.55 $5,368 - $10,827	-3,050 Reduced 0.66%	461,376 $900,000
Q2 2022 Aug 04, 2022	SELL	$1.71 - $3.71 $24,186 - $52,474	-14,144 Reduced 2.96%	464,426 $511,000
Q2 2021 Aug 09, 2021	SELL	$6.65 - $9.95 $34,852 - $52,147	-5,241 Reduced 1.08%	478,570 $4.38 Million
Q1 2021 May 03, 2021	BUY	$8.67 - $21.7 $45,439 - $113,729	5,241 Added 1.1%	483,811 $4.66 Million
Q3 2020 Nov 02, 2020	BUY	$6.27 - $15.8 $3 Million - $7.56 Million	478,570 New	478,570 $3.78 Million

2.51M

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $3.57M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.